<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a metaplastic alteration of the <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelium that is detected on endoscopic examination and pathologically confirmed by the presence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> on biopsy </plain></SENT>
<SENT sid="1" pm="."><plain>Its major significance is as a predisposing factor for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, which carries a high mortality rate and a rapidly growing incidence in the United States </plain></SENT>
<SENT sid="2" pm="."><plain>Detection of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> allows for endoscopic surveillance in order to detect the potential development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> before symptoms develop, and thereby significantly increases treatment options and may lower mortality from esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Much current work in the field is aimed at reducing the risk of progression from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and in the identification of biomarkers that may predict progression towards <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is present in 10%-20% of patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) and has also been detected in patients who deny classic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms and are undergoing endoscopy for other indications </plain></SENT>
<SENT sid="5" pm="."><plain>We used an evidence-based approach to describe treatment options for patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>